CHATHAM, N.J., April 19, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP), a clinical-stage biopharmaceutical company, today announced the presentation of two posters with research ...
Diagnostic accuracy of circulating tumor DNA for early detection of colorectal cancer: A systematic review and meta-analysis. Age-stratified odds ratios and 95% confidence intervals for constipation ...
A novel, chemo-sparing strategy (BBoPCO): introducing BOT+BAL in 1L MSS mCRC to extend survival and reduce use of cytotoxic chemotherapy The BBoPCO study (Botensilimab and Balstilimab Optimization in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results